Ornithine Transcarbamylase (OTC) Deficiency Treatment Market
Rare X-linked genetic condition ornithine transcarbamylase deficiency (OTC) is characterised by total or partial absence of the enzyme ornithine transcarbamylase (OTC). One of the six enzymes involved in the urea cycle, the body's process of removing and destroying nitrogen, is Ornithine Transcarbamylase (OTC) Deficiency Treatment. A hyperammonemia (excessive buildup of nitrogen in the blood in the form of ammonia) is the result of the OTC enzyme being absent. The symptoms and physical findings connected with OTC deficiency are caused by excess ammonia, a neurotoxin, entering the central nervous system through the blood. Vomiting, a refusal to eat, deteriorating lassitude, and coma are among the symptoms.
